Tamiflu, one of the two main treatments for avian flu, doesn't seem to be as popular anymore. Scattered reports of resistance to Tamiflu and smaller than expected orders for the drug have forced Roche to reduce its production capacity.
http://www.cnbc.com/id/18330713
I guess this begs the question: well, what's next? More countries are working on their own vaccines using strains found within their borders in hopes of creating a cheaper vaccine that's more effective to their own cases. Is this a vaccine race or a struggle between developing countries and developed nation pharmaceutical corporations?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment